- Email: [email protected]
Correction to Lancet Haematol 2015; 2: e160
Corrections
Correction to Lancet Haematol 2015; 2: e160 Dupuis J, Morschhauser F, Ghesquières H, et al. Combination of romidepsin with cyclophosphamide, doxorubicin, vincristine, and prednisone in previously untreated patients with peripheral T-cell lymphoma: a non-randomised, phase 1b/2 study. Lancet Haematol 2015; 2: e160–65—In this Article, Prof Tilly and Prof Jardin’s affiliation should have been the Department of Hematology, Henri Becquerel Cancer Center, Rouen, France. This correction has been made as of April 2, 2015.
www.thelancet.com/haematology Vol 2 April 2015
e138
Correction to Lancet Haematol 2015; 2: e160 Dupuis J, Morschhauser F, Ghesquières H, et al. Combination of romidepsin with cyclophosphamide, doxorubicin, vincristine, and prednisone in previously untreated patients with peripheral T-cell lymphoma: a non-randomised, phase 1b/2 study. Lancet Haematol 2015; 2: e160–65—In this Article, Prof Tilly and Prof Jardin’s affiliation should have been the Department of Hematology, Henri Becquerel Cancer Center, Rouen, France. This correction has been made as of April 2, 2015.
www.thelancet.com/haematology Vol 2 April 2015
e138